Evidence map›Paper›PMID 39168978›Full record

ArticleNature communications2024

A class I PI3K signalling network regulates primary cilia disassembly in normal physiology and disease.

Sarah E Conduit, Wayne Pearce, Amandeep Bhamra, Benoit Bilanges, Laura Bozal-Basterra, Lazaros C Foukas, Mathias Cobbaut, Sandra D Castillo, Mohammad Amin Danesh, Mahreen Adil and 7 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Sarah E ConduitCell Signalling, UCL Cancer Institute, University College London, 72 Huntley Street, London, WC1E 6BT, UK. s.conduit@ucl.ac.uk.ORCID 0000-0002-5075-8851
Wayne PearceCell Signalling, UCL Cancer Institute, University College London, 72 Huntley Street, London, WC1E 6BT, UK.
Amandeep BhamraProteomics Research Translational Technology Platform, UCL Cancer Institute, University College London, 72 Huntley Street, London, WC1E 6BT, UK.
Benoit BilangesCell Signalling, UCL Cancer Institute, University College London, 72 Huntley Street, London, WC1E 6BT, UK.
Laura Bozal-BasterraCenter for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160, Derio, Spain.ORCID 0000-0002-4858-2199
Lazaros C FoukasInstitute of Healthy Ageing, Department of Genetics, Evolution and Environment, University College London, London, WC1E 6BT, UK.ORCID 0000-0002-6551-8789
Mathias CobbautSignalling and Structural Biology laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.ORCID 0000-0003-0279-0336
Sandra D CastilloEndothelial Pathobiology and Microenvironment, Josep Carreras Leukaemia Research Institute, Barcelona, Spain.ORCID 0000-0002-7007-3155
Mohammad Amin DaneshCell Signalling, UCL Cancer Institute, University College London, 72 Huntley Street, London, WC1E 6BT, UK.
Mahreen AdilCell Signalling, UCL Cancer Institute, University College London, 72 Huntley Street, London, WC1E 6BT, UK.
Arkaitz CarracedoCenter for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), Bizkaia Technology Park, Building 801A, 48160, Derio, Spain.ORCID 0000-0001-5957-1260
Mariona GrauperaCentro de Investigación Biomédica En Red de Cáncer (CIBERONC), 28029, Madrid, Spain.ORCID 0000-0003-4608-4185
Neil Q McDonaldSignalling and Structural Biology laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.ORCID 0000-0003-0975-6325
Peter J ParkerThe Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.ORCID 0000-0001-5907-6980
Pedro R CutillasCentre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, EC1M 6BQ, UK.ORCID 0000-0002-3426-2274
Silvia SurinovaProteomics Research Translational Technology Platform, UCL Cancer Institute, University College London, 72 Huntley Street, London, WC1E 6BT, UK.ORCID 0000-0003-0442-9595
Bart VanhaesebroeckCell Signalling, UCL Cancer Institute, University College London, 72 Huntley Street, London, WC1E 6BT, UK. bart.vanh@ucl.ac.uk.ORCID 0000-0002-7074-3673

Funding

Cancer Research UK 25722Cancer Research UK (CRUK) C23338/A25722Cancer Research UK (CRUK) CTRQQR-2021\100004RCUK | Biotechnology and Biological Sciences Research Council (BBSRC) BB/W007460/1Wellcome Trust CC2068
6 · The paper itself

Abstract

Primary cilia are antenna-like organelles which sense extracellular cues and act as signalling hubs. Cilia dysfunction causes a heterogeneous group of disorders known as ciliopathy syndromes affecting most organs. Cilia disassembly, the process by which cells lose their cilium, is poorly understood but frequently observed in disease and upon cell transformation. Here, we uncover a role for the PI3Kα signalling enzyme in cilia disassembly. Genetic PI3Kα-hyperactivation, as observed in PIK3CA-related overgrowth spectrum (PROS) and cancer, induced a ciliopathy-like phenotype during mouse development. Mechanistically, PI3Kα and PI3Kβ produce the PIP

Indexed as

CiliaClass I Phosphatidylinositol 3-KinasesSignal TransductionAnimalsCiliopathiesHumansKinesinsMiceClass I Phosphatidylinositol 3-KinasesKinesinsPik3ca protein, mouse

Identifiers

PMID39168978
PMCPMC11339396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.